|
|
|
 |
FDA Approval Activities for this Drug…
Equagesic (meprobamate with aspirin) Tablets, Women First HealthCare NDA 11-702/S-036 ASPIRIN; MEPROBAMATE Tablet; 325MG;200MG EQUAGESIC WOMEN FIRST | 014547 MEPROBAMATE Tablet; 200MG MEPROBAMATE Eon | 014547 MEPROBAMATE Tablet; 400MG MEPROBAMATE Eon | 080655 MEPROBAMATE Tablet; 400MG MEPROBAMATE Geneva | 009698 MEPROBAMATE Tablet; 200MG MILTOWN MEDPOINTE HLC | 009698 MEPROBAMATE Tablet; 400MG MILTOWN MEDPOINTE HLC | 083618 MEPROBAMATE Tablet; 400MG MEPROBAMATE Mylan | 084332 MEPROBAMATE Tablet; 600MG MEPROBAMATE Roxane | 083343 MEPROBAMATE Tablet; 400MG MEPROBAMATE SCHERER 016249 MEPROBAMATE Tablet; 400MG TRANMEP SOLVAY | 083494 MEPROBAMATE Tablet; 400MG MEPROBAMATE TABLICAPS | 083304 MEPROBAMATE Tablet; 200MG MEPROBAMATE Watson 085720 MEPROBAMATE Tablet; 200MG MEPROBAMATE Watson | 085721 MEPROBAMATE Tablet; 400MG MEPROBAMATE Watson | 083308 MEPROBAMATE Tablet; 400MG MEPROBAMATE Watson | 015417 MEPROBAMATE Tablet; 200MG MEPROBAMATE West Ward 015417 MEPROBAMATE Tablet; 400MG MEPROBAMATE West Ward | Equagesic (meprobamate) Tablets, Leitner Pharma, Manufacturing Change or Addition | Meprobamate Tablets, InvaGen Pharma, Approval | Meprobamate Tablets, Alembic, Ltd., Approval | Meprobamate Tablets, Taro Pharmaceutical Industries Ltd., Approval
  
|